Tuesday, 21 May 2019

Micro Guide Catheters Market to Witness Steady Growth Rate During 2018 to 2026


Medical catheters are thin tubes made from medical grade materials. They can be inserted into a body cavity mainly to allow the administration of fluids, medications, gases, and to drain out fluids or urine from the body. Catheters can be used to treat neurological, gastrointestinal, ophthalmic, urological, and cardiovascular diseases. A wide range of polymers is used for manufacturing of catheters, such as silicone rubber, thermoplastic elastomers, latex and nylon, polyurethane, and polyethylene terephthalate. Among all the polymers, silicone is considered as inert and unreactive to body fluids. The Micro guide catheter has various properties, such as hydrophobic coating with glide technology, stainless steel braid, which improves the tensile strength, responsiveness, and support for improved push ability to access and cross complex lesions with increased reliability. This is the main advantages of micro guide catheters over conventional one. Micro guide catheters can be used to treat vascular malformations, uterine fibroids, hyper-vascularized tumors, venal or pulmonary embolism, and arterial embolism.


Medtronic’s voluntary recalled for the affected products unit, distributed worldwide marked as major restraining factor

Maintaining the product quality is essential to avoid product recalls. Medtronic’s voluntary recalled many pipelines embolization devices, such as Alligator retrieval device, Ultraflow, marathon flow directed micro catheters, and X-celerator hydrophilic guidewire. This recall was conducted worldwide in 2016, due to potential separation and detachment of polytetrafluoroethylene (PTFE) coating on the parts of flow directed micro catheters.

Modern micro guide provides many features over the conventional catheters propelling the growth of micro guide catheters market in near future

Conventionally, modern disposable catheters are mainly made up of polyurethane and are provided by manufactures in different sizes for adults and pediatrics. Most advanced catheters have a thin surface hydrophobic coating, which is smooth, slippery film making the catheters safer and more comfortable to insert. Bio-compatible catheters are being used recently, which is made of a polymeric material having titanium surface. It helps to improve bio-compatibility and enhance lubricity while surgery.

Micro Guide Catheters Market - Key Players

Major Key players operating the micro guide catheters market include Cardinal Health, Asahi Intec Co., Ltd, Cook Medical, Boston Scientific Corporation, Penumbra, Inc., Merit Medical Systems, Inc., Terumo Europe NV, Medtronic Plc, Integer Holdings Corporation, and Philips N.V.

Global Micro Guide Catheters Market - Taxonomy

By types -

  • Over-the-wire micro guide catheter
  • Flow directed micro guide catheter

By therapeutic application –

  • Neurological
  • Urological
  • Cardiovascular
  • Ophthalmic
  • Gastrointestinal

To know the latest trends and insights prevalent in the keyword market, click the link below: https://www.coherentmarketinsights.com/ongoing-insight/micro-guide-catheters-market-894

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702

Wearable Medical Devices Market Analysis of Advancements For Business Expansion


Wearable medical devices consist of sensors attached to the body, which detects and monitor changes in different parts of body and organ. Increase in awareness and health facilities and advancement in technology and innovation in the devices, are some of the factors propelling the wearable medical devices market growth. Smart watch, wristband, and smartphones are some of the wearable medical devices which are targeted by the companies. This is owing to factors such as their high demand and user friendly approach, and it also reduces hospital based expenditure. In near future technology is expected to play a major role in healthcare services. These devices help pharmaceutical companies in conducting valuable clinical trials. Wearable medical devices are available in wide range having different functions such as alerting mechanism, real-time feedback, and wireless data transmission.


Innovation in technology and increase in healthcare awareness is driving market growth

Rapid advancement in technology leads to innovation in existing product and introduction of new products. Increase in health concerns, sedentary lifestyle, and rise in awareness regarding health and fitness drives the wearable medical devices market growth. Furthermore, increase in geriatric population and constant increase in lifestyle disease fuels the market. According to the United Nations Department of Economic and Social Affairs, the global geriatric population is expected to increase by 56%, from 901 million to 1.4 billion over the period of 2015-2030. Major companies concentrate on user friendly wearable medical device with various features such as Bluetooth, wireless connectivity, and long battery life. There is tremendous increase in chronic diseases such as diabetes and respiratory diseases, which has increased the use of wearable medical devices. These devices are used to record heart rate, temperature, steps taken by the patient, and glucose level of the body.

Developed regions are major growth engines of the wearable medical device market

Regional segmentation of wearable medical devices market by Coherent Market Insights comprises North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America dominates in the wearable medical devices market. Asia Pacific is expected to drive growth of wearable medical devices market over the forecast period, owing to technological advancement and increase in geriatric population in emerging countries such as India, China, and Japan. According to World Economic Forum, it is expected that geriatric population of Asia Pacific will exceed 2 billion by 2050. This is owing to factors such as rise in chronic diseases especially diabetes, increased awareness regarding the use of continuous glucose monitor, and increasing healthcare investments.

Key players to support the growth of wearable medical devices market

Various players present across the globe which are running into the competition of innovation, improved product, and user-friendly approach. Some of the major players operating in the wearable medical devices market include Life Watch AG, Google Inc., Apple, Medtronic Plc., Omron Corporation, Philips Healthcare, and Polar Electro.

Wearable medical devices market taxonomy

On the basis of application, the global wearable medical devices market is segmented into:

  • Remote Patient Monitoring
  • Sports and Fitness

On the basis of type, the global wearable medical devices market is segmented into:

  • Diagnostic Medical Devices
  • Therapeutic Medical Devices

On the basis of site of use, the global wearable medical devices market is segmented into:

  • Handheld
  • Shoe Sensor
  • Headband
  • Wrist Worn

To know the latest trends and insights prevalent in the keyword market, click the link below: https://www.coherentmarketinsights.com/ongoing-insight/wearable-medical-devices-market-841

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702

Chromatography Instruments Market Geography Trends and Growth Forecast to 2026


Chromatography is a method to separate various compounds from the mixture of sample or natural solution by various chromatographic techniques using chromatography instruments. It involves separation of biomolecules on the basis of size, type, and other attributes that needs stationary phase, mobile phase, and elutants for carrying out the separation procedure. The chromatography instrument comprises of pumps, gels, columns, detectors, and software for the system used among various chromatography types. However it is important to know the sample type for choosing the chromatography instruments. The chromatography can be analytical chromatography which is used in environmental labs and preparative chromatography which is used in pharmaceutical industry. The chromatography instruments has benefits in research due to their ability of separation, analysis, and purification of molecules in an effective manner. The chromatography instruments are used in various industries such as biotechnology, pharmaceuticals, chemical, environmental testing, food and beverages, drug discovery, and semiconductor industries.


Advantages of chromatography for the new drug development and clinical research field is propelling the growth of chromatography instruments market

According to World Journal of Pharmaceutical Sciences in 2014, over 60% of chemical analysis is done by chromatography globally. The extensive use of chromatography technology is driving the chromatography instruments market. The pharmaceutical companies focus on to reduce the cost of new drug development and improve their selectivity and resolution for their detection that is possible by using advanced chromatography techniques and which aid to drive the growth of the chromatography instruments market. Importance of chromatography in novel drug approvals, new cGMP &cGDP certification for pharmaceutical excipients, rising food safety concerns are among the major factors that are fuelling the growth of chromatography instruments market.. However, the high cost of chromatography instruments, limited availability of this instruments, stringent policies and regulations for usage are the factors hindering the growth of chromatography instruments market. Technological advancements in the analytical instruments, investments in pharmaceuticals and life science research and development, and improvements in clinical and diagnostic are expected to create opportunities in the chromatography instruments market.

Expansion of major chromatography companies in Asia Pacific zone is expected to propel the growth of chromatography instruments market

Regional segmentation of chromatography instruments market by Coherent Market Insights comprises of North America, Latin America, Europe, Africa, Asia Pacific, and Middle East. Increase in number of conferences on chromatography, and some other research and development activities on drugs and biologics are the major factors for domination of North America in chromatography instruments market. Some other factor like increase in government funding for research and development in healthcare sector are also propelling the growth of chromatography instruments market in North America.

Companies are focusing on development of technologically advanced products to hold the largest share in the chromatography instruments market

Key industries operating the chromatography instruments market includes Agilent technologies, THERMO- FISHER SCIENTIFIC incorporated, PerkinElmer Incorporated, Shimadzu Corporation, Novasep Holdings S.A.S., PALL corporation, Jasco Incorporated, GL Sciences Incorporated, PHENOMENEX Inc., and Waters corporation.

Accurate analytical results of liquid chromatography system aids the segment to hold the maximum share in chromatography instruments market

The global chromatography instruments market is segmented by system, by consumables and instruments, by end users, and by regions.

On the basis of system type, chromatography instruments market is segmented into

  • Gas chromatography system
  • Ion Exchange chromatography
  • Affinity Chromatography
  • Super critical fluid chromatography
  • Column chromatography
  • Liquid chromatography system
  • High pressure liquid chromatography
  • Ultra high pressure liquid chromatography
  • Low pressure liquid chromatography
  • Others


About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702

Monday, 20 May 2019

Vertebral Compression Fracture Devices Market Size, Volume and Revenue Forecast to 2026


The micro-breaks in the building blocks of vertebra mainly caused by bone-thinning are termed as vertebral compression fractures (VCFs). Vertebral compression fracture occurs due to compression of a single bone due to trauma. The surgical approach for VCF treatment comprises injecting bone cement through a small hole in the fractured vertebra to provide immediate pain relief and stabilization to the patient. The cementing material provides a scaffold for the spine bone for added support. Thinning of corticles, reduction in bone mineral density, and osteoporosis are the major factors causing vertebral compression fractures. Postmenopausal women are more prone to vertebral fractures. The ultimate goal of the vertebral compression fracture devices is to eliminate back pain, fuse and repair fractures, restore posture, and provide ease of movement.


Rising prevalence of osteoporosis drives the vertebral compression fracture devices market

According to the International Osteoporosis Foundation estimates in 2010, osteoporosis affects 200 million people globally with approximate 9 million new osteoporotic fractures, with 1.6 million hip fractures, 1.7 million forearm fractures, and 1.4 million clinical vertebral fractures. The rising incidence of arthritis and osteoporosis, inability of medicinal therapy to cure vertebral compression fracture to the optimum level, and the advent of minimally invasive spine surgeries drives the growth of vertebral compression fracture devices market. Moreover, short recovery period, low risk of infection, limited hospital stay, and rise in geriatric population are projected to boost the demand for VCF devices globally. However, stringent regulatory approval process and the risk of post-surgical complications such as neurological injury and compromised pulmonary function are expected to restrain the market growth.

Asia Pacific is projected to grow rapidly with the rise in healthcare expenditures to cater the unmet medical needs

Regional segmentation of the global VCF market by Coherent Market Insights comprises North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. According to the World Health Organization estimates in 2015, vertebral compression fractures (VCF) are the common type of fragility fractures with 700,000 VCF cases per year in the U.S., with 30% postmenopausal women likely to experience humerus, hip, and spine fractures, thereby propelling the demand for innovative VCF devices. North America is expected to dominate the global market, owing to the surge in procedure volumes, rising prevalence of impairments, spinal disorders such as spinal stenosis, well-defined reimbursement policies, supportive economic base, and high awareness of VCF conditions and treatments available.

Delivering high quality minimally invasive products is expected to push the manufacturing envelope

Key players operating in the global vertebral compression fracture devices market include Alphatec Holdings, Inc., Depuy Synthes, Osseon LLC, VEXIM SA, and Orthovita, Inc. The launch of innovative CurvePlus device and InterV line offers atraumatic treatment allowing pain management clinics to have a safer and quicker procedure. Other key vendors include Stryker Corporation, Zimmer Biomet Holdings, Inc., Globus Medical, Inc., DFine, Inc. and CareFusion Corporation.

Balloon kyphoplasty devices segment is expected to procure largest revenue owing to its beneficial effects

The global vertebral compression fracture devices market is segmented on the basis of technology, diagnosis, surgery, end user, and geography.

On the basis of technology, the global vertebral compression fracture devices market is segmented into:

  • Balloon Kyphoplasty Devices
  • Vertebroplasty Devices

On the basis of diagnosis, the global vertebral compression fracture devices market is segmented into:

  • X-rays, CT scan or MRI
  • Radio Scan

On the basis of surgery, the global vertebral compression fracture devices market is segmented into:

  • Open Spine Surgery
  • Minimally Invasive Spine Surgery
  • Lumbar Fusion


About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702

Clinical Data Management Market Share And Future Growth To 2026


The process of collection, documentation, and data storage, which are critical for clinical trials or procedures and to biotechnology companies and pharmaceutical manufacturers is termed as Clinical Data Management (CDM). Clinical data management tool is employed in clinical research for managing the data of a clinical trial. Data management is a process of collection, integration, and management of subject data in compliance with regulatory standards. Clinical data management is a fundamental phase in clinical research leading to the generation of high-quality, reliable, and statistically comprehensive data to reduce time duration from drug development to marketing. The clinical data is captured in a paper or electronic data capture format. Pharma companies, contract research organizations, and IT companies are involved in CDM activities. Data is collected from multiple sources and stored in a patient-centric fashion in a data repository commonly known as clinical data repository.

Get In-Depth Sample Copy of This Research @ https://www.coherentmarketinsights.com/insight/request-sample/795

Rising number of clinical trials drives the clinical data management market

Advantages of web-based data collection tools such as reduced time and ease in data entry, low cost, flexibility in format, and the ability to capture additional response-set information drive the clinical data management market. Additionally, high levels of productivity and efficiency offered by clinical data management are expected to redefine the traditional data management process by the companies thereby augmenting the clinical data management market growth. Also, increase in research and development expenditure of clinical research and life science industries coupled with increasing number of clinical trials is a factor contributing to the growth of clinical data management market.

North America is expected to dominate the market due to rise in demand for patient data standardization

Regional segmentation of clinical data management market by Coherent Market Insights comprises North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. According to the National Institutes of Health estimates in 2015, around 89,528 clinical trials were conducted in the U.S., which, in turn, raised the demand for storing comprehensive statistical patient data in. Moreover, the growth of North America market is driven by increasing need for data standardization and rising investments by biotechnology and pharmaceutical companies in research and development. The surging growth in Asia Pacific is attributed to a number of factors including rise in outsourcing of clinical trials, availability of diverse patient population, and less regulatory guidelines by the government.

Top Key Players

Key players operating the clinical data management market include OmniComm Systems, Oracle Corporation, BioClinicia, ERT, PHT Corporation, MedNet Solutions Inc., PAREXEL International Corporation, eClinical Solutions Inc., Datatrak International Inc., and Medidata Solutions, Inc.

Focus on high-quality clinical data by Oracle Clinical segment fuels the market growth

The global clinical data management market is segmented on the basis of tools, service, delivery mode, end-use industry, and geography.

On the basis of tools, the global clinical data management market is segmented into:

  • Oracle Clinical
  • Clintrial
  • Macro
  • Rave
  • eClinical Suite

On the basis of services, the global clinical data management market is segmented into:

  • Case Report Form (CRF) Designing
  • Data Entry and Validation
  • Discrepancy Management
  • Medical Coding
  • Others


About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702

Myelodysplastic Syndrome Treatment Market Growing at Steady CAGR to 2025


Myelodysplastic (MDS) syndrome is a type of bone marrow disorder, where bone marrow is unable to produce healthy and mature blood cells. The immature blood cells called as blasts, get stored in the bone marrow and blood and obstruct the natural function of the hematological system which results in depletion of healthy red blood cells, platelets, and white blood cells. Myelodysplastic syndrome is usually seen in geriatric population and more often in older men than women. This syndrome is characterized by certain chromosomal mutations in Janus Kinase gene which include deletion of q arm in one or more chromosomes and complete deletion of chromosome 5 or 7 and an extra copy of chromosome 8. There are various types of myelodysplastic syndrome such as refractory cytopenia with unilineage dysplasia and refractory anemia with ringed sideroblasts among others. Approved drugs for MDS include Vidaza (Azacitidine), Revlimid (Lenalidomide), Decitabine (Dacogen), and Deferasirox (Jadenu). Revlimid (Lenalidomide) patent for MDS indication will be expiring in 2023. A number of generic azacitidine-based products for MDS are launched in the global market.


Rising implications associated with myelodysplastic syndrome are expected to affect the myelodysplastic syndrome treatment market

According to the American Cancer Society, the incidence rate for myelodysplastic syndrome is 13,000 new cases each year which happens at a rate of 4.8 cases per 100,000 people. This trend is heavily affected or rather influenced by the average age of the population which, according to the World Health Organization (WHO), is increasing and is expected to double from 12% to 22% between 2015 and 2050. Furthermore, according to the American Society of Clinical Oncology (ASCO), age plays an important role in the occurrence of myelodysplastic syndrome as most of the people diagnosed with the disease are of age 65 and older. These factors are expected to boost the myelodysplastic syndrome treatment.

The global myelodysplastic syndrome treatment market was valued at US$ 2,213.2 million in 2017 and is expected to witness a CAGR of 12.7% during the forecast period (2017 – 2025).

Endeavor to introduce highly effective therapies for various MDS types would support the market growth

Major pharmaceutical organizations such as Celgene are investing major amounts in research and development of MDS specific drugs and many of their drugs are showing potential in the clinical trials as shown in the table no.1. Furthermore, in 2016, Opsona Therapeutics Ltd. received orphan drug designation for its OPN-305 humanized IgG4 monoclonal antibody for MDS treatment. Also, after Celgene lost its U.S. exclusivity for Vidaza, many generic formulations have entered in the market for Vidaza and Natco Pharma is also expected to launch generic version of Vidaza in 2017, which will further boost myelodysplastic syndrome treatment market.

Global Key Players

Key players operating in the myelodysplastic syndrome treatment market include Celgene, Novartis, and Otsuka. Some of the other market players are Astellas, Astex, Acceleron Pharma, Onconova Pharmaceuticals, GlaxoSmithKline, Eli-Lilly, and CTI Biopharma.

Detailed Segmentation:

Global Myelodysplastic syndrome treatment market, By Drug:
  • Azacitidine
  • Lenalidomide
  • Decitabine
  • Deferasirox

Global Myelodysplastic syndrome treatment market, By Geography:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa


About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702

Saturday, 18 May 2019

Computer Aided Detection Market: The Evolution of Future Healthcare Industry


Computer Aided Detection (CAD) software is a set of algorithms that uses pattern recognition method assisting physicians with interpretation of medical images. Increasing number of patients opting for diagnostic imaging techniques is expected to propel the volume of image data to be analyzed. It is a diagnostic analysis technology, which assists physicians in reducing detection errors. CAD software is helpful in diagnosis of several diseases, such as cancer, coronary artery disease, cardiovascular diseases, and neurological diseases through imaging modalities, such as X-Rays imaging, Magnetic Resonance Imaging ultrasound imaging, and computed tomography. It helps in accurate detection of chronic diseases in early stages, reducing mortality rates due to cancer, cardiovascular, and neurological diseases.


Increase in prevalence of the chronic diseases is anticipated to fuel the demand of Computer Aided Detection Market

Increasing cancer treatment awareness and routine medical check-up is driving the demand for CAD market. Advanced digital imaging techniques have enhanced the effectiveness and efficiencies of CAD solutions. Easy integration with various imaging equipment is helping with early detection of chronic diseases. It has applications in clinical and research and development activities. Medical tourism is also boosting the adoption of CAD. Gradual increase in demand for Health Insurance, which requires pre-screening of chronic diseases is driving the growth of CAD market. Major investments in R&D of Computer Aided Detection with 3D imaging are providing opportunities for growth of the market. High cost is the challenge for growth of CAD market.

Intense merger and acquisition among the emerging players to boost the computer aided detection market

Key players involved in global computer aided detection market are GE Healthcare, Philips Healthcare, Hologic,Inc., Inc. iCAD, Agfa-Gevaert N.V., EDDA Technology, Fujifilm Medical System, Invivo Corporation, Hitachi Medical Corporation, and Siemens Healthineers. GE Healthcare got FDA clearance for its Senographe Pristina Dueta, which is claimed to be the 1st patient-assisted mammography device that allows women to control their own compression during the examination. GE healthcare has transform the mammography for reducing the pain during examination. Philips Healthcare has entered an agreement with Belgium-headquartered IBA (ION Beam Applications SA) for providing proton therapy solutions, it is an advanced therapy for treatment of cancer in India.

Computer Aided Detection Market - Taxonomy

Computer Aided Detection Market is segmented on the basis of application, end users, imaging modalities

On the basis of application, the global computer aided detection in healthcare market can be segmented as.

  • Lung cancer
  • Breast cancer
  • Liver cancer
  • Bone cancer
  • Prostate cancer
  • Colorectal cancer
  • Others (Cardiovascular and Neurological Indications etc.)

On the basis of imaging modalities, the global Computer Aided Detection market in healthcare market can be segmented as

  • Ultrasound imaging
  • Mammography
  • Tomosynthesis
  • Computed tomography
  • Magnetic resonance imaging


About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702

Myasthenia Gravis Treatment Market Major Trends & Development Opportunities until 2027


Myasthenia gravis (MG) is a type of chronic autoimmune neuromuscular disease which causes weakness in skeletal muscles in the arms and legs. Double vision, facial paralysis, difficulty in walking, dropping of eyelids, are symptoms of myasthenia gravis. This disease is diagnosed by tests such as repetitive nerve stimulation test, blood test for antibodies, edrophonium test, Computed Tomography (CT), and Magnetic Resonance Imaging (MRI). Corticosteroids drugs (azathioprine, and cyclosporine) and Acetylcholine esterase inhibitors (Edrophonium, and Pyridostigmine) are used for the treatment of MG.


Myasthenia Gravis Treatment Market - Drivers

Consistent research and development activities are expected to propel growth of the myasthenia gravis treatment market. For instance, in October 2017, Alexion Pharmaceuticals, Inc. received approval from the U.S. Food and Drug Administration for Soliris which contains eculizumab as an active component. This drug is used for treatment of antibody positive generalized myasthenia gravis, and it is also used in treatment of paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS).

Increasing number of clinical trials for treatment of myasthenia gravis are expected to drive the myasthenia gravis treatment market growth. For instance, in December 2017, Novartis AG initiated phase II clinical trial of CFZ533 for treatment of severe myasthenia gravis. The main function of CFZ533 is the modification of immune response by deactivation of white blood cells. Hence, it is expected to help with improvement and management of severe myasthenia gravis.

Myasthenia Gravis Treatment Market - Regional Analysis

On the basis of region, the global myasthenia gravis treatment market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected to hold a dominant position in the myasthenia gravis treatment market over the forecast period. This is owing to increasing incidence and prevalence of myasthenia gravis in the U.S. For instance, in October 2018, according to the National Center for Biotechnology Information (NCBI), incidence of myasthenia gravis was around 5 to 30 cases per million person years and prevalence is around 10 to 20 cases per 100,000 population in U.S.

Myasthenia Gravis Treatment Market - Competitive Analysis

Key players operating in the myasthenia gravis treatment market are Novartis AG, Takeda Pharmaceutical Company Limited, Grifols, S.A., Valeant Pharmaceutical International, Inc. Alexion Pharmaceutical Inc., F. Hoffmann-La Roche AG, CSL Behring, Baxter International, Inc., Shire plc, and Avadel Pharmaceutical, PLC.

Myasthenia Gravis Treatment Market – Taxonomy

By Medications

  • Cholinesterase Inhibitors
  • Corticosteroids
  • Immunosuppressants
  • Plasmapheresis
  • Intravenous immunoglobulin (IVIg)
  • Monoclonal Antibody

By Distribution Channels

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies


About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702

Friday, 17 May 2019

Spirometer Market Surge in Demand from Medical Device Industry


Difficulty in breathing is a major problem among people across the world. Spirometer is a common test / device used to diagnose and aid in treatment of certain lung diseases. It measures inhalation and exhalation volume of air in one breath. Spirometer is used to diagnose Chronic Obstructive Pulmonary Disease (COPD) and asthma. It is also used to monitor other lung conditions such as chronic bronchitis, pulmonary fibrosis, and emphysema.

Spirometer Market Drivers

Increasing prevalence of respiratory diseases and disorders is expected to propel growth of the spirometer market. According to The World Health Organization’s (WHO) report 2016, around 235 million people suffer from asthma worldwide annually. COPD is a progressive, life -threatening disease, which causes blockage into the air tubes. Hence increasing number of respiratory disease demands for more spirometers and thus support the global spirometer market growth.


Key players in the market are focused on launching new products, which is expected to boost growth of the spirometer market. For instance, in April 2018, NuvoAir AB launched smart wireless spirometer for home use. It is a small, wireless, and portable device that can be easily connected to smartphones via Bluetooth.

Spirometer Market- Regional Analysis

On the basis of region, the global spirometer market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected to hold dominant position in the spirometer market. This is owing to increasing collaboration activities and high incidences of respiratory diseases and disorders in the region. For instance, in December 2016, Propeller Health collaborated with Medical International Research (MIR). Under this collaboration, Propeller Health incorporated MIR’s clinical spirometer into its digitally-guided respiratory therapy platform to improve management of respiratory conditions such as COPD and asthma.

Spirometer Market- Competitive Analysis

Key players operating in the spirometer market include Care Fusion, Philips Healthcare, Welch Allyn, NuVoAir, Propeller Health, Medical International Research, Cardioline, Sibelmed, Cosmed, Masimo Corporation and Fisher, and Paykel Healthcare Limited.

Spirometer Market – Taxonomy

By Technology:

  • Flow Measurement
  • Volume Measurement
  • Peak Flow Measurement

By Indication:

  • Asthma
  • COPD
  • Chronic Bronchitis
  • Pulmonary Fibrosis
  • Cystic Fibrosis
  • Emphysema

Find the comprehensive research report here with a single click: https://www.coherentmarketinsights.com/ongoing-insight/spirometer-market-2615

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702

Cell Culture Media for Vaccine Market To Receive Overwhelming Hike In Revenues By 2026


Cell culture media consists an appropriate source of energy and compounds, which supports growth of cells and regulate the cell cycle. A typical culture medium is composed of vitamins, inorganic salts, complement of amino acids, glucose, and serum which acts as source of growth factors, hormones, and attachment factors. Furthermore, the medium also helps to maintain pH and osmolality.

Market Dynamics

Increasing prevalence of infectious diseases is a major factor driving the global cell culture media for vaccine market growth. According to the Centers for Disease Control and Prevention (CDC), in August 2017, around 104 laboratory-confirmed influenza-associated pediatric deaths were reported, where 66 cases were associated with influenza A viruses and 38 cases were associated with influenza B viruses in the U.S. Moreover, the government initiatives for increasing awareness among the populace regarding prevention of diseases facilitated by vaccines is expected to boost the market growth. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2015, flu vaccinations prevented around 1.9 million flu illnesses, 966,000 flu-associated medical visits, and around 67,000 flu-associated hospitalizations, representing 6.5% lowering of disease burden in the U.S.

Get Sample Copy Of The Cell Culture Media for Vaccine Market Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/2608

Increasing prevalence of infectious diseases is expected to propel growth of the global cell culture media for vaccine market

High prevalence of infectious diseases is expected to drive the market growth over the forecast period. According to the Centers for Disease Control and Prevention (CDC), in 2017, around 9,105 tuberculosis cases and around 42,743 cases of lyme disease were reported in the U.S. Also, according to the study conducted by University of Oxford, 2018, the measles cases are currently high in several European countries, where over 82,500 measles cases were registered in Europe in 2018. The number was thrice as compared in 2017, while 15 times in comparison with 2016.

Increasing investments by government organizations and manufacturers focusing on promoting immunization in North America is expected to bolster the market growth

The increasing investments by government organizations and manufacturers focusing on promoting immunization is expected to drive the cell culture media for vaccine market. For instance, in 2015, the Centers for Medicare & Medicaid Services (CMS), with the Centers for Disease Control and Prevention (CDC) introduced a five-year initiative, Healthy People 2020 to improve immunization as well as to reduce the disparity rates caused majorly due to pneumonia, shingles, and influenza. The organizations worked directly with physicians and provider offices, home health agencies, hospitals, and beneficiaries under the guidance of Health Service Advisory Group (HSAG) to promote their initiative.

Key Players

Major players operating in the global cell culture media for vaccine market include HiMedia Laboratories, Thermo Fisher Scientific Inc., Merck KGaA, General Electric Company, Sartorius AG, Proliant, Inc., Bovogen Biologicals Pty. Ltd., Rocky Mountain Biologicals, Valley Biomedical, Moregate BioTech, Atlanta Biologicals, Creative-Biolabs, Life Technologies (India) Pvt Ltd., Axil Scientific Pte Ltd., Indian Immunologicals Limited, Serum Institute of India Pvt. Ltd., Sisco Research Laboratories Pvt. Ltd., and Valneva SE.


Detailed Segmentation:

Global Cell Culture Media for Vaccine Market, By Application:
  • Human Vaccines
  • Animal Vaccines

Global Cell Culture Media for Vaccine Market, By Media Type:
  • Bovine Derived
    • Fetal bovine serum (FBS)
    • Newborn Calf Serum (NBCS)
    • Adult Bovine Serum (ABS)
    • Bovine Serum Albumin (BSA)
    • Bovine Calf Serum (BCS)
  • Porcine Derived
  • Animal free/Serum Free Cell Culture


About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702